Ticker brief
TRXB
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
6
authors 14d
5
crowd 14d
+0.10
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-10-08 → 2026-10-12 · now +0.00 (−1 bearish … +1 bullish)
Who spoke5
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @IPODave | B | -0.45 | 2 | +0.30 |
| @Optimalinvestme | C | -2.28 | 1 | +0.00 |
| @fwpharma | B | -1.91 | 1 | -0.15 |
| @HammerstoneMar3 | C | +0.30 | 1 | +0.15 |
| @theflynews | C | · | 1 | +0.00 |
Recent signals6of 6 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-12 | @theflynews | +0.00 | Reports the public-market debuts of Retension and TRex Bio. | · | tweet ↗ |
| 2026-10-09 | @HammerstoneMar3 | +0.15 | Describes TRXB opening below its $14 IPO price, rebounding and holding a $13.50 intraday average. | · | tweet ↗ |
| 2026-10-09 | @IPODave | +0.15 | Says biotech dominates current IPO activity despite a sector bear market and may rebound. | · | tweet ↗ |
| 2026-10-09 | @IPODave | +0.45 | Holding a small TRXB starter and will wait for price confirmation before sizing up. — Discloses a new $13.50 starter buy and conditional plan to keep the position small. | · | tweet ↗ |
| 2026-10-09 | @fwpharma | -0.15 | TRex priced its IPO at the range bottom while Retension made an oversized debut. | · | tweet ↗ |
| 2026-10-08 | @Optimalinvestme | +0.00 | Reports today's biotech IPOs at $12 for RTSN and $14 for TRXB. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.